Capreomycin

  • Trade name Capreomycin
  • INN Capreomycin
  • ATC Code [J04AB30]
  • Marketing authorization number ЛП-000100
Description
Second-line anti-tuberculosis drug – key component in the therapy of tuberculosis caused by multidrug-resistant mycobacteria. High clinical efficacy (90% or more) and relatively good tolerance. Administered intravenously or intramuscularly.
  • Dosage
  • Dosage form
  • Quantity per package
  • Solvent
  • Quantity of solvent
  • 0,75 g
  • Vial
  • 50
  • -
  • -
  • 0,75 g
  • Vial
  • 10
  • -
  • -
  • 0,75 g
  • Vial
  • 5
  • Water for inj
  • 5
  • 0,75 g
  • Vial
  • 5
  • -
  • -
  • 0,75 g
  • Vial
  • 1
  • Water for inj
  • 1
  • 0,75 g
  • Vial
  • 1
  • -
  • -
  • 0,5 g
  • Vial
  • 50
  • -
  • -
  • 0,5 g
  • Vial
  • 10
  • -
  • -
  • 0,5 g
  • Vial
  • 5
  • Water for inj
  • 5
  • 0,5 g
  • Vial
  • 5
  • -
  • -
  • 0,5 g
  • Vial
  • 1
  • Water for inj
  • 1
  • 0,5 g
  • Vial
  • 1
  • -
  • -

This website uses cookies and similar technologies to assist with navigation, enhance your user experience, and analyze usage of our products and services.
I agree